Opinion: Reducing Whistleblower Risk
Opinion: Reducing Whistleblower Risk
Helene Z. Hill | Feb 11, 2014
It takes significant time and money for a scientist to defend his or her accusation of research misconduct.
Watson Opposes Gene Patents
Jef Akst | Jul 19, 2012
James Watson files a brief in the ongoing legal case over Myriad Geneticsā€™ right to hold patents on the BRCA1 and BRCA2 genes.
Misconduct Hearing Granted
Hannah Waters | Mar 9, 2012
A cancer researcher charged with scientific misconduct in 2011 may have the right to present his defense—a rare occurrence under current regulations.